Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 248 | -571 | 41,656 | 1,477 | 1,815 |
| Gross Profit | 248 | -571 | 41,656 | 1,477 | 1,815 |
| Operating Expenses | 10,514 | 12,383 | 4,920 | 12,564 | 11,140 |
| Operating Income | -10,266 | -12,954 | 36,736 | -11,087 | -9,325 |
| Other Income | 12 | 14 | 12 | 13 | 12 |
| Pre-tax Income | -10,254 | -12,940 | 36,748 | -11,074 | -9,313 |
| Income Tax | N/A | -763 | -227 | 1 | N/A |
| Net Income Continuous | -10,254 | -12,177 | 36,975 | -11,075 | -9,313 |
| Net Income | $-10,254 | $-12,177 | $36,975 | $-11,075 | $-9,313 |
| EPS Basic Total Ops | -0.15 | -0.16 | 0.53 | -0.16 | -0.15 |
| EPS Basic Continuous Ops | -0.15 | -0.16 | 0.53 | -0.16 | -0.15 |
| EPS Diluted Total Ops | -0.15 | -0.14 | 0.51 | -0.16 | -0.15 |
| EPS Diluted Continuous Ops | -0.15 | -0.14 | 0.51 | -0.16 | -0.15 |
| EBITDA(a) | $-10,134 | $-10,728 | $37,454 | $-10,954 | $-9,181 |